DK0500791T3 - Udformning og konstruktion af ikke-infektiøse human retrovirale mutanter, der mangler genomisk DNA - Google Patents

Udformning og konstruktion af ikke-infektiøse human retrovirale mutanter, der mangler genomisk DNA

Info

Publication number
DK0500791T3
DK0500791T3 DK91900636.1T DK91900636T DK0500791T3 DK 0500791 T3 DK0500791 T3 DK 0500791T3 DK 91900636 T DK91900636 T DK 91900636T DK 0500791 T3 DK0500791 T3 DK 0500791T3
Authority
DK
Denmark
Prior art keywords
cys
retroviruses
infectivity
array
amino acids
Prior art date
Application number
DK91900636.1T
Other languages
English (en)
Inventor
Stephen Oroszlan
Louis E Henderson
Robert J Gorelick
Alan R Rein
Larry O Arthur
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of DK0500791T3 publication Critical patent/DK0500791T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK91900636.1T 1989-10-31 1990-10-31 Udformning og konstruktion af ikke-infektiøse human retrovirale mutanter, der mangler genomisk DNA DK0500791T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42928789A 1989-10-31 1989-10-31

Publications (1)

Publication Number Publication Date
DK0500791T3 true DK0500791T3 (da) 1998-04-06

Family

ID=23702610

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91900636.1T DK0500791T3 (da) 1989-10-31 1990-10-31 Udformning og konstruktion af ikke-infektiøse human retrovirale mutanter, der mangler genomisk DNA

Country Status (10)

Country Link
EP (1) EP0500791B1 (da)
JP (1) JPH0716420B2 (da)
AT (1) ATE162949T1 (da)
AU (1) AU636755B2 (da)
CA (1) CA2072125C (da)
DE (1) DE69032028T2 (da)
DK (1) DK0500791T3 (da)
ES (1) ES2111559T3 (da)
GR (1) GR3026457T3 (da)
WO (1) WO1991006318A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861282A (en) * 1989-10-16 1999-01-19 Whitehead Institute For Biomedical Research Non-infectious HIV particles and uses therefor
US5532154A (en) * 1994-03-21 1996-07-02 Research Development Foundation Mutated alpha virus
AU737926B2 (en) 1996-05-20 2001-09-06 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Oligonucleotides which specifically bind retroviral nucleocapsid proteins
US20040009193A1 (en) * 2000-08-08 2004-01-15 Yuko Morikawa Virus-like micrograins and process for producing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05501201A (ja) * 1989-10-16 1993-03-11 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ 非感染性ｈｉｖ―１粒子およびそれらの使用

Also Published As

Publication number Publication date
EP0500791A4 (en) 1993-02-10
DE69032028T2 (de) 1998-05-20
DE69032028D1 (de) 1998-03-12
ATE162949T1 (de) 1998-02-15
WO1991006318A1 (en) 1991-05-16
ES2111559T3 (es) 1998-03-16
JPH04505163A (ja) 1992-09-10
JPH0716420B2 (ja) 1995-03-01
EP0500791B1 (en) 1998-02-04
AU7740291A (en) 1991-05-31
CA2072125C (en) 2000-05-23
AU636755B2 (en) 1993-05-06
EP0500791A1 (en) 1992-09-02
CA2072125A1 (en) 1991-05-01
GR3026457T3 (en) 1998-06-30

Similar Documents

Publication Publication Date Title
Simon et al. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes
Leis et al. Standardized and simplified nomenclature for proteins common to all retroviruses
Peters et al. Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein
ES2052591T3 (es) Variantes de virus lav, sus componentes de adn y de proteinas, y sus utilizaciones particularmente con fines diagnosticos y para la preparacion de composiciones inmunogenicas.
KR920703639A (ko) 항-바이러스제와 이뮤노겐으로 유용하게 사용되는 비-복제성 리콤비넌트 레트로바이러스 물질
DK0887427T3 (da) Amplifikation og detektion af HIV-1 og/eller HIV-2
DE69033896D1 (de) Gentechnologische herstellung von impfstoffen gegen aids und andere retrovirale krankheiten
WO1990015066A3 (fr) Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus
Henderson et al. Gag precursors of HIV and SIV are cleaved into six proteins found in the mature virions
Mselli-Lakhal et al. Lack of functional receptors is the only barrier that prevents caprine arthritis-encephalitis virus from infecting human cells
DE69836395D1 (de) Primern zum Nachweis von HIV-1
DE69032028D1 (de) Entwurf und konstruktion von nichtinfektiösen menschlichen retrovirusmutanten mit mangel an genomischer rna
Davis et al. Conserved cysteines of the human immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virions
KR890701738A (ko) 인체면역결핍 비루스 특이성 단백질분해효소와 이들의 합성 및 원형재현 방법
Fujita et al. Amino acid residues 88 and 89 in the central hydrophilic region of human immunodeficiency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif
WO1998038325A3 (de) Retrovirale vektoren, verfahren zu ihrer herstellung und ihre verwendung zur genübertragung in cd4-positive zellen
Yang et al. Long polymerase chain reaction amplification of heterogeneous HIV type 1 templates produces recombination at a relatively high frequency
Bailes et al. The evolution of primate lentiviruses and the origins of AIDS
DK631387A (da) Virusvektor
DE68929419D1 (de) Prototypische FeLV-Isolate für die Verwendung als Krankheitsmuster oder Impfstoff
Meyerhans et al. The non-clonal and transitory nature of HIV in vivo
Gray et al. Nucleotide sequence of the core (gag) gene from HTLV-1 isolate MT-2
MY104530A (en) Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for pro- phylaxis and therapy against human retroviruses.
Inubushi et al. Cell-dependent function of HIV-1 Vif for virus replication
Wrobel et al. Analysis of HIV type 1 reverse transcriptase: comparing sequences of viral isolates with mutational data